PrepRARE Webinar STRIDES Study for SCA3
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=9xfSAfItq5U
STRIDES Study for SCA3 - A Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia • Seelos Therapeutics physicians provided an overview of the STRIDES study, which is currently open to patient recruitment in the United States. The overview will include background information on the Investigational drug, SLS-005, patient eligibility criteria, study center locations, and other important study design elements. • Learn more about how to enroll in the study: https://bit.ly/3R0ot69 • Learn more about clinical trials for Ataxias: www.ataxia.org/ClinicialTrials • Learn more about Ataxia: www.ataxia.org
#############################